Here are five facts:
1. In the last four weeks, the company’s shares posted positive gains of 3.63 percent.
2. Amedica shares underperformed the S&P 500 by 3.58 percent in the last week.
3. The company outperformed the index by nearly 12 percent in the last four weeks.
4. During the last three-month period, Amedica shares fell 55.63 percent.
5. The 50-day moving average is $0.12 and the 200-day moving average is $0.31.
More articles on devices:
Global hip, knee orthopedic surgical robots market to reach $5B by 2022 — 4 things to know
LDR Holding partners with Poly-Shape for spinal implant manufacturing: 5 points
SpineFrontier appoints Jerry Goldstein to board of directors — 4 key points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
